Global Drug Repurposing Market 2020 by Company, Regions, Type and Application, Forecast to 2025


Apr, 2020 | Report ID: 132041 | 127 | Pharmaceuticals and Healthcare

Market Overview
The global Drug Repurposing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 28190 million by 2025, from USD 25270 million in 2019.
The Drug Repurposing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drug Repurposing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Repurposing market has been segmented into:
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
By Application, Drug Repurposing has been segmented into:
Hospitals
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Repurposing market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Repurposing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Repurposing market.
The report offers in-depth assessment of the growth and other aspects of the Drug Repurposing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Repurposing Market Share Analysis
Drug Repurposing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Repurposing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Repurposing sales, revenue and market share for each player covered in this report.
The major players covered in Drug Repurposing are:
Astellas Pharma
AbbVie
Biovista
NuMedii
Novartis
Allergan
Pfizer

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Drug Repurposing Market Overview
1.1 Product Overview and Scope of Drug Repurposing
1.2 Classification of Drug Repurposing by Type
1.2.1 Global Drug Repurposing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drug Repurposing Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 CNS Diseases
1.2.5 Neurodegenerative Diseases
1.2.6 Others
1.3 Global Drug Repurposing Market by Application
1.3.1 Overview: Global Drug Repurposing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Drug Repurposing Market by Regions
1.4.1 Global Drug Repurposing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drug Repurposing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drug Repurposing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drug Repurposing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Repurposing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drug Repurposing Status and Prospect (2015-2025)
1.4.7 Middle East& Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Repurposing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma SWOT Analysis
2.1.4 Astellas Pharma Product and Services
2.1.5 Astellas Pharma Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biovista
2.3.1 Biovista Details
2.3.2 Biovista Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biovista SWOT Analysis
2.3.4 Biovista Product and Services
2.3.5 Biovista Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.4 NuMedii
2.4.1 NuMedii Details
2.4.2 NuMedii Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 NuMedii SWOT Analysis
2.4.4 NuMedii Product and Services
2.4.5 NuMedii Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Allergan SWOT Analysis
2.6.4 Allergan Product and Services
2.6.5 Allergan Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drug Repurposing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Repurposing Players Market Share
3.2.2 Top 10 Drug Repurposing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drug Repurposing Revenue and Market Share by Regions
4.2 North America Drug Repurposing Revenue and Growth Rate (2015-2020)
4.3 Europe Drug Repurposing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Repurposing Revenue and Growth Rate (2015-2020)
4.5 South America Drug Repurposing Revenue and Growth Rate (2015-2020)
4.6 Middle East& Africa Drug Repurposing Revenue and Growth Rate (2015-2020)
5 North America Drug Repurposing Revenue by Countries
5.1 North America Drug Repurposing Revenue by Countries (2015-2020)
5.2 USA Drug Repurposing Revenue and Growth Rate (2015-2020)
5.3 Canada Drug Repurposing Revenue and Growth Rate (2015-2020)
5.4 Mexico Drug Repurposing Revenue and Growth Rate (2015-2020)
6 Europe Drug Repurposing Revenue by Countries
6.1 Europe Drug Repurposing Revenue by Countries (2015-2020)
6.2 Germany Drug Repurposing Revenue and Growth Rate (2015-2020)
6.3 UK Drug Repurposing Revenue and Growth Rate (2015-2020)
6.4 France Drug Repurposing Revenue and Growth Rate (2015-2020)
6.5 Russia Drug Repurposing Revenue and Growth Rate (2015-2020)
6.6 Italy Drug Repurposing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drug Repurposing Revenue by Countries
7.1 Asia-Pacific Drug Repurposing Revenue by Countries (2015-2020)
7.2 China Drug Repurposing Revenue and Growth Rate (2015-2020)
7.3 Japan Drug Repurposing Revenue and Growth Rate (2015-2020)
7.4 Korea Drug Repurposing Revenue and Growth Rate (2015-2020)
7.5 India Drug Repurposing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Repurposing Revenue and Growth Rate (2015-2020)
8 South America Drug Repurposing Revenue by Countries
8.1 South America Drug Repurposing Revenue by Countries (2015-2020)
8.2 Brazil Drug Repurposing Revenue and Growth Rate (2015-2020)
8.3 Argentina Drug Repurposing Revenue and Growth Rate (2015-2020)
9 Middle East& Africa Revenue Drug Repurposing by Countries
9.1 Middle East& Africa Drug Repurposing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drug Repurposing Revenue and Growth Rate (2015-2020)
9.3 UAE Drug Repurposing Revenue and Growth Rate (2015-2020)
9.4 Egypt Drug Repurposing Revenue and Growth Rate (2015-2020)
9.5 South Africa Drug Repurposing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drug Repurposing Revenue and Market Share by Type (2015-2020)
10.2 Global Drug Repurposing Market Forecast by Type (2019-2024)
10.3 Oncology Revenue Growth Rate (2015-2025)
10.4 CNS Diseases Revenue Growth Rate (2015-2025)
10.5 Neurodegenerative Diseases Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Drug Repurposing Market Segment by Application
11.1 Global Drug Repurposing Revenue Market Share by Application (2015-2020)
11.2 Drug Repurposing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Drug Repurposing Market Size Forecast (2021-2025)
12.1 Global Drug Repurposing Market Size Forecast (2021-2025)
12.2 Global Drug Repurposing Market Forecast by Regions (2021-2025)
12.3 North America Drug Repurposing Revenue Market Forecast (2021-2025)
12.4 Europe Drug Repurposing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drug Repurposing Revenue Market Forecast (2021-2025)
12.6 South America Drug Repurposing Revenue Market Forecast (2021-2025)
12.7 Middle East& Africa Drug Repurposing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Drug Repurposing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Repurposing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Repurposing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drug Repurposing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Astellas Pharma Corporate Information, Location and Competitors
Table 6. Astellas Pharma Drug Repurposing Major Business
Table 7. Astellas Pharma Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 8. Astellas Pharma SWOT Analysis
Table 9. Astellas Pharma Drug Repurposing Product and Solutions
Table 10. Astellas Pharma Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AbbVie Corporate Information, Location and Competitors
Table 12. AbbVie Drug Repurposing Major Business
Table 13. AbbVie Drug Repurposing Total Revenue (USD Million) (2018-2019)
Table 14. AbbVie SWOT Analysis
Table 15. AbbVie Drug Repurposing Product and Solutions
Table 16. AbbVie Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Biovista Corporate Information, Location and Competitors
Table 18. Biovista Drug Repurposing Major Business
Table 19. Biovista Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 20. Biovista SWOT Analysis
Table 21. Biovista Drug Repurposing Product and Solutions
Table 22. Biovista Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. NuMedii Corporate Information, Location and Competitors
Table 24. NuMedii Drug Repurposing Major Business
Table 25. NuMedii Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 26. NuMedii SWOT Analysis
Table 27. NuMedii Drug Repurposing Product and Solutions
Table 28. NuMedii Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Drug Repurposing Major Business
Table 31. Novartis Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Drug Repurposing Product and Solutions
Table 34. Novartis Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Allergan Corporate Information, Location and Competitors
Table 36. Allergan Drug Repurposing Major Business
Table 37. Allergan Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 38. Allergan SWOT Analysis
Table 39. Allergan Drug Repurposing Product and Solutions
Table 40. Allergan Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Drug Repurposing Major Business
Table 43. Pfizer Drug Repurposing Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Drug Repurposing Product and Solutions
Table 46. Pfizer Drug Repurposing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Drug Repurposing Revenue (Million USD) by Players (2015-2020)
Table 48. Global Drug Repurposing Revenue Share by Players (2015-2020)
Table 49. Global Drug Repurposing Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Drug Repurposing Revenue Market Share by Regions (2015-2020)
Table 51. North America Drug Repurposing Revenue by Countries (2015-2020)
Table 52. North America Drug Repurposing Revenue Market Share by Countries (2015-2020)
Table 53. Europe Drug Repurposing Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Drug Repurposing Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Drug Repurposing Revenue by Countries (2015-2020)
Table 56. South America Drug Repurposing Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Drug Repurposing Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2015-2020)
Table 59. Global Drug Repurposing Revenue (Million USD) by Type (2015-2020)
Table 60. Global Drug Repurposing Revenue Share by Type (2015-2020)
Table 61. Global Drug Repurposing Revenue Forecast by Type (2021-2025)
Table 62. Global Drug Repurposing Revenue by Application (2015-2020)
Table 63. Global Drug Repurposing Revenue Share by Application (2015-2020)
Table 64. Global Drug Repurposing Revenue Forecast by Application (2021-2025)
Table 65. Global Drug Repurposing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drug Repurposing Picture
Figure 2. Global Drug Repurposing Revenue Market Share by Type in 2019
Figure 3. Oncology Picture
Figure 4. CNS Diseases Picture
Figure 5. Neurodegenerative Diseases Picture
Figure 6. Others Picture
Figure 7. Drug Repurposing Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Others Picture
Figure 11. Global Drug Repurposing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Drug Repurposing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drug Repurposing Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Drug Repurposing Revenue Market Share in 2019
Figure 20. Global Top 10 Players Drug Repurposing Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Drug Repurposing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Drug Repurposing Revenue Market Share by Regions (2015-2020)
Figure 24. Global Drug Repurposing Revenue Market Share by Regions in 2018
Figure 25. North America Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 26. Europe Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 28. South America Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 30. North America Drug Repurposing Revenue Market Share by Countries (2015-2020)
Figure 31. North America Drug Repurposing Revenue Market Share by Countries in 2019
Figure 32. USA Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 33. Canada Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Drug Repurposing Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Drug Repurposing Revenue Market Share by Countries in 2019
Figure 37. Germany Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 38. UK Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 39. France Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 40. Russia Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 41. Italy Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Drug Repurposing Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Drug Repurposing Revenue Market Share by Countries in 2019
Figure 44. China Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 45. Japan Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 46. Korea Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 47. India Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 49. South America Drug Repurposing Revenue Market Share by Countries (2015-2020)
Figure 50. South America Drug Repurposing Revenue Market Share by Countries in 2019
Figure 51. Brazil Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 56. UAE Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Drug Repurposing Revenue and Growth Rate (2015-2020)
Figure 59. Global Drug Repurposing Revenue Share by Type (2015-2020)
Figure 60. Global Drug Repurposing Revenue Share by Type in 2019
Figure 61. Global Drug Repurposing Market Share Forecast by Type (2021-2025)
Figure 62. Global Oncology Revenue Growth Rate (2015-2020)
Figure 63. Global CNS Diseases Revenue Growth Rate (2015-2020)
Figure 64. Global Neurodegenerative Diseases Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Drug Repurposing Revenue Share by Application (2015-2020)
Figure 67. Global Drug Repurposing Revenue Share by Application in 2019
Figure 68. Global Drug Repurposing Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Drug Repurposing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Drug Repurposing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Drug Repurposing Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Drug Repurposing Revenue Market Forecast (2021-2025)
Figure 76. Europe Drug Repurposing Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Drug Repurposing Revenue Market Forecast (2021-2025)
Figure 78. South America Drug Repurposing Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Drug Repurposing Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Sample Request is not available